# Ultra Seal Corporation – FDA Inspection, Sep 3, 2026

Source: https://www.keypedia.com/records/fda_inspections/ultra-seal-corporation/1c499379-feb6-4045-ae46-b2ca42a28530
Source feed: FDA_Inspections

> FDA inspection 1338618 of Ultra Seal Corporation, September 03, 2026. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1338618
- Company Name: Ultra Seal Corporation
- Inspection Date: 2026-09-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New York District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1263334 - 2025-03-04](https://www.keypedia.com/records/fda_inspections/ultra-seal-corporation/f4a128f6-cbf0-48bf-8268-7dbc27f4e6bb)
- FDA Inspection 1229281 - 2024-05-02
- FDA Inspection 1228761 - 2024-02-05
- [FDA Inspection 1218129 - 2023-09-20](https://www.keypedia.com/records/fda_inspections/ultra-seal-corporation/c19adf9f-5907-48fb-b684-902b8d26346c)
- [FDA Inspection 1157142 - 2021-11-19](https://www.keypedia.com/records/fda_inspections/ultra-seal-corporation/646b6b1b-8fb2-4804-90b0-421383f1a299)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/daniel-t-lee/8147e5b2-2065-42e3-b86c-36c0231f74cc)
- Issuing Officer

Company: https://www.keypedia.com/companies/ultra-seal-corporation/cf5b79d4-f6e6-4417-82f6-2ff3c6160a3c

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d